Ultragenyx Pharmaceutical Inc.

Historical 13F Holders

Symbol
RARE
CUSIP
90400D108
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 27 1.80 M $65.5 M
2025 Q1 328 88.9 M $3.22 B
2024 Q4 342 87.5 M $3.68 B
2024 Q3 325 86.3 M $4.79 B
2024 Q2 289 89.4 M $3.67 B
2024 Q1 290 81.2 M $3.79 B
2023 Q4 260 81.8 M $3.91 B
2023 Q3 240 71.3 M $2.54 B
2023 Q2 259 69.5 M $3.21 B
2023 Q1 243 69.2 M $2.77 B
2022 Q4 242 71.0 M $3.29 B
2022 Q3 254 68.3 M $2.83 B
2022 Q2 236 67.9 M $4.05 B
2022 Q1 256 67.8 M $4.91 B
2021 Q4 250 67.7 M $5.69 B
2021 Q3 229 66.7 M $6.01 B
2021 Q2 253 65.7 M $6.26 B
2021 Q1 274 67.9 M $7.73 B
2020 Q4 277 68.0 M $9.42 B
2020 Q3 216 63.2 M $5.20 B
2020 Q2 209 63.4 M $4.96 B
2020 Q1 188 60.8 M $2.70 B
2019 Q4 185 59.4 M $2.54 B
2019 Q3 182 59.1 M $2.53 B
2019 Q2 188 60.9 M $3.86 B
2019 Q1 189 58.4 M $4.05 B
2018 Q4 175 51.2 M $2.23 B
2018 Q3 192 50.6 M $3.87 B
2018 Q2 169 49.1 M $3.78 B
2018 Q1 174 49.3 M $2.51 B
2017 Q4 176 43.3 M $2.01 B
2017 Q3 167 40.6 M $2.17 B
2017 Q2 172 41.3 M $2.56 B
2017 Q1 177 40.8 M $2.76 B
2016 Q4 187 41.8 M $2.94 B
2016 Q3 192 39.7 M $2.82 B
2016 Q2 173 37.0 M $1.82 B
2016 Q1 171 37.4 M $2.37 B
2015 Q4 185 36.2 M $4.06 B
2015 Q3 176 35.7 M $3.49 B
2015 Q2 161 32.5 M $3.33 B
2015 Q1 132 31.6 M $1.96 B
2014 Q4 103 28.0 M $1.23 B
2014 Q3 107 26.5 M $1.50 B
2014 Q2 86 20.4 M $828 M
2014 Q1 78 18.9 M $815 M